The authors concluded that the coexistence of anti-Ro/SSA52 and anti-Jo-1 antibodies could serve as a valuable predictor for the development of a more severe and advanced form of ILD in patients with IIM. The gene discussed is CALR; the disease is interstitial lung disease.